Impact of the Affordable Care Act on Innovation, Access, and Affordability for Drugs and Biologics - CANCELED

The third lecture in the Implementing Health Care Reform in California Lecture Series will be presented by Kent Lieginger, PharmD, senior vice president, managed care and customer operations at Genentech.
With 25 years in the pharmaceutical and biotech industries, Kent Lieginger has held a variety of leadership roles in managed care, U.S. and global business development, finance, strategic contracting, manufacturing, marketing and sales. During his tenure at Genentech, he has been recognized for innovation in distribution, contracting, reimbursement, account management, and pricing.

Room 101